WillowWood Global, Mount Sterling, Ohio, announced that it has entered into a strategic partnership with Blue Sea Capital, a growth-oriented private equity firm.
As part of the strategic partnership, Blue Sea has made a substantial equity investment in WillowWood. WillowWood’s management team will maintain its meaningful ownership in the company.
“Since partnering with Ryan Arbogast in 2019, Daniel [Rubin] and I have taken great pride in transforming a closely held, fourth generation family-owned business into what is today the preeminent player in prosthetic products,” said Mahesh Mansukhani, WillowWood CEO. “Having executed our operational playbook, our partnership with Blue Sea marks an important milestone in WillowWood’s long-term growth trajectory.”
Rubin, WillowWood COO, said, “The company intentionally selected Blue Sea as its preferred partner, based on the team’s impressive track record supporting similarly growth-oriented healthcare businesses, with both organic and acquisition-driven initiatives.”
“Having spent several years diligently tracking its journey, we are thrilled to partner with WillowWood and its management team to support their next stage of growth,” said Erin Lansky, Blue Sea vice president. “We’re confident they’ll continue to set the industry standard for product innovation and integrity and, as such, level the playing field for patients worldwide.”
